Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Abstract Dipeptidyl peptidase IV (DPP-IV) inhibitors improve glycemic control by prolonging the action of glucagon-like peptide-1 (GLP-1)
For a 1.7mg dose: 1.7 divided by 3.33 equals 0.51mL, which is 51 units
In the pivotal late stage REASSURE study, Iterums drug showed statistical non-inferiority to Augmentin (amoxicillin/clavulanate) in terms of overall response, and in the pivotal Phase III SURE 1 study, Orlynvah outperformed ciprofloxacin in patients with quinolone-resistant infections
Lancet Diabetes Endocrinol 2:691700
US$ 25.49
US$ 21.25
US$ 22.55
US$ 27.61
US$ 26.56
US$ 28.94
US$ 23.36
US$ 27.04
US$ 26.83
